You will not be allowed to compare more than 4 products at a time
View compareDescription
SOBREPIN AEROSOL 40 mg/3 ml nebuliser solution
Sobrerol
What it is and what it is used for
The active ingredient in Sobrefluid is sobrerol, a mucolytic.
This medicine is indicated for facilitating the removal of excess mucus in acute and chronic respiratory tract conditions.
Consult your doctor if you do not feel better or if you feel worse after 3 days.
What you need to know before taking the medicine
Do not use SOBREPIN AEROSOL
- if you are allergic to sobrerol or any of the other ingredients of this medicine (listed in section 6);
- if you are pregnant or breastfeeding. (see Pregnancy and breastfeeding);
- in children under 30 months of age;
- in children with a history of epilepsy or febrile convulsions.
Warnings and precautions
Consult your doctor or pharmacist before using SOBREPIN AEROSOL.
Pay particular attention:
This medicine contains sobrerol which, in excessive doses, can cause neurological disorders such as convulsions in infants and children.
Do not prolong treatment for more than 3 days due to the risks associated with the accumulation of terpene derivatives in the Sobrepin AEROSOL FI 1a body, including the brain, and in particular due to the risks of neuropsychological disorders.
Do not administer doses higher than those recommended to avoid a greater risk of adverse drug reactions and disorders associated with overdose.
Children
The product must not be used in children under 30 months of age, as mucolytics can cause bronchial obstruction (the ability to eliminate bronchial mucus in children under 30 months is limited due to the characteristics of their respiratory tracts).
Possible side effects
Like all medicines, this medicine can cause side effects, although not everybody gets them.
Side effects with unknown frequency (frequency cannot be estimated from the available data):
- allergic (hypersensitivity) reactions manifesting as itching, rash, urticaria, oedema and dyspnoea;
- bronchial obstruction (temporary narrowing of the upper airways);
- gastric disorders (stomach problems);
- nausea.
Reporting of side effects
If you get any side effects, including any not listed in this leaflet, talk to your doctor or pharmacist. You can also report side effects directly via the national reporting system at: https://www.aifa.gov.it/content/segnalazionireazioni-avverse.
By reporting side effects you can help provide more information on the safety of this medicine.


